Cindy Hayashi
Responsable des Ressources Humaines chez CARIBOU BIOSCIENCES, INC.
Provenance du réseau au premier degré de Cindy Hayashi
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 21 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Cindy Hayashi via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
GILEAD SCIENCES, INC. | Biotechnology | Sales & Marketing | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ARROWHEAD PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
EXELIXIS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | General Counsel | |
Consolidated Edison Company of New York, Inc.
Consolidated Edison Company of New York, Inc. Electric UtilitiesUtilities Consolidated Edison Co. of New York, Inc. engages in the distribution of electric power services. It operates through the following segments: Electric, Gas, and Steam. The company was founded in 1884 and is headquartered in New York, NY. | Electric Utilities | Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Graduate Degree | |
University of California, Los Angeles | College/University | Undergraduate Degree | |
Bryn Mawr College | College/University | Undergraduate Degree | |
The Johns Hopkins University | College/University | Graduate Degree | |
University of British Columbia | College/University | Undergraduate Degree Undergraduate Degree | |
St. Mary's College of California | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
University of California, Irvine | College/University | Undergraduate Degree Graduate Degree | |
University of Puget Sound | College/University | Undergraduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Young Womens Christian Association USA
Young Womens Christian Association USA Services to the Health IndustryHealth Services Young Womens Christian Association USA operates as a multicultural women's organization. It provides shelters, child care, employment training, job placement, and youth development programs for women. The firm also sponsors racial justice, antiviolence, and human rights advocacy programs. Young Women's Christian Association was founded in 1855 and is headquartered in Washington, DC. | Services to the Health Industry | Chief Executive Officer | |
Barnard College | College/University | Director/Board Member | |
Susan G. Komen for the Cure
Susan G. Komen for the Cure Miscellaneous Commercial ServicesCommercial Services Susan G. Komen for the Cure conducts research for breast cancer treatment. It is an non-profit organization engages in breast cancer cure research and fund raising activities. The company was founded by Nancy Goodman Brinker in 1982 and is headquartered in Dallas, TX. | Miscellaneous Commercial Services | Chief Executive Officer | |
Kenan-Flagler Business School | College/University | Masters Business Admin | |
Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
The Hastings Center | Director/Board Member | ||
JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Perelman School of Medicine | College/University | Doctorate Degree | |
The Leonard N Stern School of Business | College/University | Masters Business Admin | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
The University of Miami Leonard M. Miller School of Medicine | College/University | Doctorate Degree | |
INTELLIA THERAPEUTICS, INC. | Biotechnology | Founder | |
BEIGENE, LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
HARPOON THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
SEER, INC. | Biotechnology | Director/Board Member | |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Miscellaneous Commercial Services | Director/Board Member | |
BHLF LLP | Founder | ||
ZYMEWORKS INC. | Pharmaceuticals: Major | Director/Board Member | |
Drh Consulting LLC | Chief Executive Officer | ||
GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
New York University School of Medicine | College/University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 46 |
Canada | 4 |
Îles Cayman | 2 |
Danemark | 2 |
Sectorielle
Health Technology | 20 |
Consumer Services | 19 |
Commercial Services | 6 |
Health Services | 3 |
Distribution Services | 2 |
Opérationnelle
Director/Board Member | 49 |
Corporate Officer/Principal | 38 |
Undergraduate Degree | 20 |
Chief Tech/Sci/R&D Officer | 19 |
Independent Dir/Board Member | 18 |
Relations les plus connectées
Insiders | |
---|---|
Scott Braunstein | 26 |
Jenny Rooke | 17 |
Andrew Guggenhime | 13 |
Natalie Sacks | 13 |
Barbara McClung | 12 |
Dara Richardson-Heron | 11 |
Timothy Kelly | 9 |
Syed Rizvi | 9 |
Jeffrey Long-McGie | 8 |
Cherry Thomas | 7 |
Nancy Whiting | 7 |
Inui Edny | 7 |
Rachel Haurwitz | 7 |
Ruhi Khan | 6 |
Ran Zheng | 6 |
- Bourse
- Insiders
- Cindy Hayashi
- Connexions Sociétés